Please try another search
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. It has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. Tango Therapeutics, Inc. was founded in 2017 and is headquartered in Boston, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
Carole L. Nuechterlein | 59 | 2020 | Independent Director |
Aaron I. Davis | 43 | 2020 | Chairman & CEO |
James G. Christensen | 53 | 2020 | Independent Director |
Charles M. Baum | 63 | 2020 | Independent Director |
Christopher Fuglesang | 52 | 2020 | President & Director |
Richard A. Heyman | 64 | - | Independent Director |
James B. Avery | 58 | 2020 | Independent Director |
Barbara L. Weber | 66 | 2017 | President, CEO & Director |
Alexis A. Borisy | 51 | 2017 | Independent Chairman |
Malte Peters | 61 | 2018 | Independent Director |
John G. Doench | - | 2021 | Member of Scientific Advisory Board |
Mace L. Rothenberg | 66 | 2021 | Independent Director |
Lesley Ann Calhoun | 57 | 2021 | Independent Director |
Ulrich Elling | - | 2021 | Member of Scientific Advisory Board |
John Ketchum | - | 2023 | Independent Director |
Kanishka Ram Pothula | 39 | 2023 | Independent Director |
William G. Kaelin | 66 | 2021 | Founder & Member of Scientific Advisory Board |
Alan Ashworth | 62 | 2021 | Founder & Member of Scientific Advisory Board |
Antoni Ribas | 57 | 2021 | Founder & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review